Epidemiology of Malaria Transmission in Low to Moderate Settings of Latin America

拉丁美洲中低度地区疟疾传播的流行病学

基本信息

项目摘要

The main objective of project 1 is to evaluate the diversity of the ecology and parasite populations related to the epidemiology and clinical findings in order to establish a scientific framework that supports the development of new intervention strategies for malaria elimination in non-Amazonian areas of LA. This goal will be approached through the following specific aims: 1) Study the epidemiology of seasonal malaria and their relationship with parasite population diversity and 2) Identification risk factors associated with malaria transmission in non-Amazonian areas of LA countries. We hypothesize that circulating Plasmodium populations and their dynamics modulate the clinical manifestations and immune responses in the affected populations and that vector bionomics, parasite population diversity, host biology and behavior, household conditions, and local environmental conditions, act simultaneously to determine malaria transmission and risk of infection. The studies proposed for aim 1 are directed to determine the real prevalence and incidence of malaria by considering both symptomatic and asymptomatic individuals living in seasonal areas in LA. This investigation includes community based cohort studies (prospective studies), active surveillance using temporal cross-sectional studies, and hospital based passive surveillance studies. The studies will be carried out in 7 endemic areas of Colombia, Peru, Panama and Guatemala, where a total of 21 sentinel sites will be studied. Studies will be carried out in three phases: 1) Our own census of the selected population from sentinel sites where inhabitants will be registered using a demographic questionnaire and houses coordinates using a GPS system; 2) thick smear and PCR for malaria diagnose in selected sentinels sites and random sampling in order to determine asymptomatic gametocytes carriers; 3) clinical follow-up and thick smear of asymptomatic at two sentinel sites (one in Colombia (Tierralta) and one in Peru (Sulluna). For aim 2 we will a) assess the conditions of antimalarial use in communities where malaria is endemic, including adherence, self-medication and prophylaxis; and (b) study the conditions of use of antimalarials in the public and private health institutions including the availability and suitability to care guides. In this ICEMR program, we will establish a network of sentinel sites that will be selected integrating bio-geographic criteria (vector and ecological conditions) and epidemiological information. Sentinel sites will provide baseline information on malaria ecology and epidemiology with the goal of characterizing parasite and vector populations resilient to control interventions. Such network will allow supporting current efforts directed to develop population models to quantify disease dynamics and malaria risk-maps to support MOH elimination activities.
项目1的主要目标是评估与流行病学和临床发现有关的生态和寄生虫种群的多样性,以便建立一个科学框架,支持制定新的干预战略,在洛杉矶非亚马逊地区消除疟疾。将通过以下具体目标实现这一目标:1)研究季节性疟疾的流行病学及其与寄生虫种群多样性的关系; 2)确定与洛杉矶国家非亚马逊地区疟疾传播有关的风险因素。 我们假设循环疟原虫种群及其动力学调节临床 我们认识到,疟疾的传播和感染风险与病媒生物学特性、寄生虫种群多样性、宿主生物学和行为、家庭条件和当地环境条件同时起作用。为目标1提议的研究旨在通过考虑生活在洛杉矶季节性地区的有症状和无症状的个人,确定疟疾的真实的流行率和发病率。 本研究包括基于社区的队列研究(前瞻性研究)、使用时间横断面研究的主动监测和基于医院的被动监测研究。这些研究将在哥伦比亚、秘鲁、巴拿马和危地马拉的7个流行地区进行,总共将对21个监测点进行研究。研究将分三个阶段进行:(1)我们自己对哨点选定人口进行普查,在哨点使用人口调查表登记居民,并使用全球定位系统提供坐标;(2)在选定哨点进行厚涂片和聚合酶链反应疟疾诊断,并随机抽样,以确定无症状配子体携带者;(3)临床随访, 在两个哨点(一个在哥伦比亚(蒂尔拉尔塔),一个在秘鲁(Sulluna))发现无症状的厚涂片。对于目标2,我们将:(a)评估疟疾流行社区的抗疟药物使用情况,包括坚持使用、自我用药和预防;(B)研究公共和私营卫生机构的抗疟药物使用情况,包括护理指南的可用性和适用性。在ICEMR计划中,我们将建立一个哨点网络,将选择生物地理标准(媒介和生态条件)和流行病学信息相结合。哨点将提供关于疟疾生态学和流行病学的基线信息,目的是确定寄生虫和病媒种群对控制干预措施的适应能力。这种网络将有助于支持目前旨在发展人口的努力, 量化疾病动态的模型和疟疾风险图,以支持卫生部的消除活动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Socrates Herrera Valencia其他文献

Socrates Herrera Valencia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Socrates Herrera Valencia', 18)}}的其他基金

DISCOVERY AND PRECLINICAL DEVELOPMENT OF EFFICACIOUS P. vivax PRE-ERYTHROCYTIC STAGE MALARIA VACCINES
有效的红细胞前阶段疟疾疫苗的发现和临床前开发
  • 批准号:
    10513808
  • 财政年份:
    2020
  • 资助金额:
    $ 34.46万
  • 项目类别:
DISCOVERY AND PRECLINICAL DEVELOPMENT OF EFFICACIOUS P. vivax PRE-ERYTHROCYTIC STAGE MALARIA VACCINES
有效的红细胞前阶段疟疾疫苗的发现和临床前开发
  • 批准号:
    10305627
  • 财政年份:
    2020
  • 资助金额:
    $ 34.46万
  • 项目类别:
Discovery and preclinical evaluation of Plasmodium falciparum and P. vivax coiled coil antigens for malaria vaccine development
用于疟疾疫苗开发的恶性疟原虫和间日疟原虫卷曲螺旋抗原的发现和临床前评估
  • 批准号:
    10323004
  • 财政年份:
    2020
  • 资助金额:
    $ 34.46万
  • 项目类别:
Discovery and preclinical evaluation of Plasmodium falciparum and P. vivax coiled coil antigens for malaria vaccine development
用于疟疾疫苗开发的恶性疟原虫和间日疟原虫卷曲螺旋抗原的发现和临床前评估
  • 批准号:
    10079466
  • 财政年份:
    2020
  • 资助金额:
    $ 34.46万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8319231
  • 财政年份:
    2011
  • 资助金额:
    $ 34.46万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8009913
  • 财政年份:
    2010
  • 资助金额:
    $ 34.46万
  • 项目类别:
Latin American Center for Malaria Research and Control
拉丁美洲疟疾研究与控制中心
  • 批准号:
    8319233
  • 财政年份:
    2010
  • 资助金额:
    $ 34.46万
  • 项目类别:
Epidemiology of Malaria Transmission in Low to Moderate Settings of Latin America
拉丁美洲中低度地区疟疾传播的流行病学
  • 批准号:
    8009908
  • 财政年份:
    2010
  • 资助金额:
    $ 34.46万
  • 项目类别:
Latin American Center for Malaria Research and Control
拉丁美洲疟疾研究与控制中心
  • 批准号:
    8895238
  • 财政年份:
    2010
  • 资助金额:
    $ 34.46万
  • 项目类别:
Latin American Center for Malaria Research and Control
拉丁美洲疟疾研究与控制中心
  • 批准号:
    7945673
  • 财政年份:
    2010
  • 资助金额:
    $ 34.46万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了